Clinical trial Recruiting at 1 site Interventional Ages Any age to 85

Lying‑Sitting‑Standing Baduanjin to improve heart and lung function in acute coronary syndrome with heart failure

Official title: A Clinical Study on the Effect of Cardiopulmonary Function and Quality of Life in Patients With Acute Coronary Syndrome Complicated by Heart Failure by "Lying-Sitting-Standing" Sequential Baduanjin

Run by Second Hospital of Shanxi Medical University · NCT07486791 · Data updated 2026-11-12

This study will test whether a gentle sequence of Baduanjin exercises performed lying, sitting, and standing helps people hospitalized with acute coronary syndrome and heart failure improve heart and lung function and quality of life.

Quick facts

Study typeInterventional
AgesAny age to 85 Years
SexAll
Enrollment65 (estimated)
SponsorSecond Hospital of Shanxi Medical University
Academic / other
Locations1 site (Taiyuan, Shanxi)
StatusRecruiting
StartedMarch 10, 2026
Main results expectedMarch 1, 2027
Study endsJune 1, 2027
Registry record updatedMay 5, 2026
Trial IDNCT07486791 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Ideal candidates are people hospitalized with ACS who develop heart failure, are age 85 or younger, have at least grade‑3 muscle strength, are conscious, and can provide informed consent.

Probably not a fit

Patients with persistent NYHA class IV symptoms despite optimal therapy, uncontrolled arrhythmias or hypertension, hemodynamic instability, untreated structural heart disease, or other acute severe illnesses are unlikely to benefit or be eligible.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

Participants with acute coronary syndrome complicated by heart failure will receive standard medical treatment and routine rehabilitation nursing guidance, with some patients also doing a sequential lying‑sitting‑standing Baduanjin exercise program. The intervention group will perform the Baduanjin sequence alongside usual care while the comparison group receives usual care alone. Cardiopulmonary function and quality of life will be measured using echocardiography, NT‑proBNP, 6‑minute walk test, NYHA class, and the SF‑36 questionnaire. Results will be compared to see if this low‑intensity exercise sequence can be a viable early cardiac rehabilitation option.

Why it matters

Potential benefit: If effective, this simple, low‑cost exercise sequence could improve cardiopulmonary function and quality of life and offer a practical early cardiac rehabilitation option for these patients.

How similar studies have gone: Previous smaller studies of Baduanjin and similar Qigong exercises have shown promise for cardiac rehabilitation outcomes, but the specific lying‑sitting‑standing sequential approach is relatively novel and less studied.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

* Patients meeting the diagnostic criteria for ACS (including unstable angina, non-ST-segment elevation myocardial infarction, and ST-segment elevation myocardial infarction)
* Complicated by heart failure during hospitalization
* Age ≤ 85 years
* Muscle strength ≥ grade 3
* No history of mental illness, conscious and able to cooperate independently with this study
* Voluntarily participate in this study and sign the informed consent form

Exclusion Criteria:

* Patients with persistent heart failure symptoms or NYHA functional class IV despite optimal pharmacological therapy;
* Patients with contraindications to cardiac rehabilitation, such as uncontrolled hypertension, uncontrolled arrhythmias, or hemodynamic instability;
* Patients with untreated structural heart disease, such as heart failure caused by valvular heart disease or congenital heart disease;
* Patients in the acute phase of various diseases, such as severe infection, deep vein thrombosis, or severe hepatic or renal failure;
* Patients with disabilities, bone or joint diseases, or neurological disorders that preclude participation in Baduanjin exercises;
* Patients with a life expectancy of less than one year;
* Patients currently participating in other clinical trials.

Where it's running

  • Second Hospital of Shanxi Medical
    Taiyuan, Shanxi, China
    Recruiting

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

  • EHR-guided LDL cholesterol optimization after a heart event

    A pharmacist-guided program using electronic health records to help adults in Alberta reach LDL goals after a heart event by adjusting medications and ordering tests.

    Recruiting at 2 sites University of Alberta · Edmonton, Alberta and 1 other locations · NCT07685639

  • AI ECG test to spot LV dysfunction in adults

    A deep learning ECG tool is being tested to see if it can reliably flag left ventricular systolic dysfunction (LVEF ≤40%) in adults who also have an echocardiogram.

    Recruiting Ajou University School of Medicine · Suwon, Gyeonggi-do · NCT07636759

  • Dapagliflozin for Coronary Inflammation in Stage 4 CKM Syndrome After ACS

    This trial tests whether daily dapagliflozin can lower heart artery inflammation and slow plaque growth in adults with stage 4 CKM syndrome after acute coronary syndrome.

    Recruiting Phase 4 Shenyang Northern Hospital · Shenyang, Liaoning · NCT07351643

  • EuroHeart Italy registry for acute coronary syndrome, heart failure, and atrial fibrillation

    This project will collect health information to see if following ESC quality indicators improves care for adults treated for acute coronary syndrome, heart failure, or atrial fibrillation.

    Recruiting at 38 sites Heart Care Foundation · Montevarchi, AREZZO and 56 other locations · NCT07283809

  • Outcomes after PCI using the Protégé paclitaxel drug-coated balloon.

    This registry will collect real-world data to see if the Protégé paclitaxel drug-coated balloon works well and is safe for adults having PCI for coronary artery disease or acute coronary syndrome.

    Recruiting Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) · Amsterdam · NCT07231835

  • Cardiovascular problems after allogeneic stem cell transplant

    This study looks at heart-related problems after allogeneic hematopoietic stem cell transplantation to see how often they occur and what factors might predict them.

    Recruiting Assistance Publique - Hôpitaux de Paris · Paris · NCT07157670

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.